Aim To identify factors found in the research literature to be associated with smoking cessation in pregnancy. Methods Electronic searches of the bibliographic databases of PubMed, EMBASE, PsycINFO, Elsevier, Scopus and ISI Web of Science were conducted to April 2017. All studies reporting factors associated with smoking cessation or continuing smoking during pregnancy were included and reviewed systematically, irrespective of study design. The NewcastleOttawa Quality Assessment Scale was used to assess the study quality. The DerSimonian & Laird random-effects model was used to conduct meta-analyses, and where effect estimates were reported for factors included in at least three studies.
INTRODUCTION
Smoking in pregnancy is a serious public health problem and one of the main preventable causes of pregnancyrelated morbidity and death. Smoking is associated with adverse pregnancy and birth outcomes, including miscarriage, stillbirth, prematurity, low birth weight, intrauterine growth restriction, congenital abnormalities and neonatal or sudden infant death [1] [2] [3] [4] [5] . Smoking also presents immediate risks for the mother, including placental abruption [6] , as well as the longer-term risks reported for smokers in general [7] .
In high-income countries, the prevalence of smoking in pregnancy is estimated to be between 10 and 26% and is decreasing rapidly in many of these countries [8] [9] [10] [11] [12] whereas, in low-and middle-income countries the prevalence is between 15 and 37% and is not declining in some of these countries [13] [14] [15] [16] . Smoking cessation during pregnancy improves maternal and birth outcomes [17] , yet only approximately 25% of pregnant smokers stop for at least part of their pregnancy and half to two-thirds of them return to smoking after giving birth [18] . Regular sessions of face-to-face behavioural support is the main intervention demonstrated to be effective as an aid to smoking cessation during pregnancy [17] , which can be enhanced when supplemented with financial incentives [19] .
To promote successful maternal smoking cessation during pregnancy, clinicians and researchers need to identify factors that facilitate or inhibit the quitting process. These factors can then be targeted directly, by smoking cessation interventions, or indirectly by promoting cessation interventions to subgroups of women who are less likely to succeed at quitting [20, 21] . For example, this might include women from socially deprived groups, those with higher levels of cigarette dependence and women living with a partner who smokes [22, 23] .
The most recent systematic review of predictors of smoking cessation during pregnancy was conducted in 2010 [23] and considered 19 studies which identified socio-demographic/economic, relationship, psychological, pregnancy and health-related factors as predictors. However, this review was limited to studies in high-income countries published between 1997 and 2008, and excluded intervention studies. There have been a large number of studies published since this previous review was undertaken. Furthermore, additional factors have since been examined as predictors of cessation during pregnancy, such as smoking dependence variables (e.g. Fagerström Test for Cigarette Dependence and urges to smoke), as well as variables related to pregnancy, such as adequate pre-natal care, planned breast feeding and planned pregnancy. Moreover, a meta-analysis has not been conducted previously on this topic. This comprehensive systematic review was conducted to examine a wide range of factors that may be associated with smoking cessation during pregnancy. Further aims include conducting meta-analysis for the frequently reported factors and classifying factors associated with cessation into subcategories, including socio-demographic/ economic, relationship and social activity, smoking, psychological, pregnancy and health-related factors, to help clinicians to target interventions towards different subgroups of the pregnant population or to inform the development of interventions.
METHODS

This review was conducted according to the Preferred
Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) statement [24] .
Strategies for searching the literature
We developed a search strategy and conducted the literature searches in the bibliographic databases of PubMed, '] . Based on the combinations of these terms, several searches were conducted in the abovementioned databases. We examined all the studies included in the previous review [23] . There was no restriction on language and the search was completed in April 2017.
Inclusion and exclusion criteria
Smoking cessation or continued smoking during pregnancy were considered as the analyses outcomes. This included biochemically validated and non-validated selfreported smoking cessation, and covered both planned and spontaneous quit attempts [25] at any time during pregnancy. Studies were included which examined statistically the association of smoking cessation or continuing smoking during pregnancy with other factors, irrespective of study design. If a study was designed to evaluate an intervention, such as nicotine replacement therapy, we did not report the intervention as a predictor. We excluded those studies which include non-smoking women before pregnancy, women who had stopped smoking prior to pregnancy, studies reporting predictors of postpartum smoking cessation and qualitative studies (i.e. narrative and case reports). Studies identified by search strategies were screened for eligibility; initially on the basis of title and abstract, and then reading the full text of the remaining studies. One reviewer (M.R.) screened all studies for inclusion, with one-third also screened independently by another reviewer (M.U.), with 100% agreement. A handsearch of the reference lists of included studies was also conducted. Corresponding authors were contacted for additional information where necessary.
Data extraction
The following data were extracted from each study by M.R. and were verified by M.U.: first author name, year and location of publication, study aim and design, participant characteristics, including age and smoking behaviours, sample size and smoking cessation rate, main outcome measure, biochemical validation, whether all smokers made a quit attempt, variables examined as predictors, statistical methods used for the analysis and statistically significant predictors reported and effect estimates for the association [e.g. odds ratios (OR) and 95% confidence intervals (CI)].
To aid the description, those factors found to be associated significantly with smoking cessation were categorized by grouping similar factors thematically across the included papers. The categories were decided through reference to categories used in a review by Schneider and colleagues [23] and through discussion involving all authors. Potential predictors were grouped into the following domains: socio-demographic/economic, relationship, smoking/substance misuse, psychological, pregnancy and health-related factors. They were also categorized according to the nature of association with smoking cessation (i.e. increasing or decreasing OR).
Meta-analyses
A large number of factors associated significantly with smoking cessation during pregnancy are identified in this review. However, to pool the effect estimates in a way that will yield valuable information about the direction and size of effects and to quantify heterogeneity among the included studies, we conducted meta-analyses for those factors whose effect estimates were available from at least three studies. We extracted the effect estimates (95% CI), reported as OR (majority), relative risk ratios (RR: one study [26] ) or prevalence ratios (PR: one study [21] ). If an effect estimate was not reported, an unadjusted OR and 95% CI was estimated from the available data. To ensure consistency of the effect estimates for meta-analysis, for some of the studies the effect estimates were transformed such that the appropriate reference category was used with smoking cessation as the outcome. For example, for the meta-analysis of older maternal age as a categorical predictor, we extracted effect estimate (ORs) for the oldest versus the youngest age category. If a study reported an effect estimate for the youngest age category versus oldest age category, we transformed the OR (95% CI) by taking the multiplicative inverse. Similarly, if a study reported OR (95% CI) for continuing smoking versus quitting, we used the multiplicative inverse to compute OR (95% CI) for quitting versus continuing smoking. Assuming heterogeneity of effects, we used DerSimonian & Laird [27] random-effects model for the meta-analyses to compute pooled effect estimates and a heterogeneity index I 2 . The meta-analyses results were reported as pooled OR (95% CI), with I 2 and P-values.
Quality assessment
The included studies were randomized controlled trials (RCTs) and observational (cohort and cross-sectional). To assess study quality, we used the Newcastle-Ottawa Quality Assessment Scale (NOQAS) developed for cohort studies [28] and the modified version of the (NOQAS) developed for cross-sectional studies [29] . In the modified version of the scale, criteria for the 'ascertainment of exposure' was not applicable in this review, therefore we used the original criteria as given in the NOQAS for cohort studies. For predictors' analyses, the overall sample of the RCT had been used as for observational cohorts; therefore, we assessed the quality of RCTs using the cohort studies scale of NOQAS.
The maximum possible score of NOQAS was 9 and we used a standard cut-off of 7 to identify studies with high quality methodology. Studies were included in the review irrespective of their rating of quality. Quality assessment was conducted by two independent reviewers (M.R. and S.L.), who discussed any discrepancies until agreement was met.
RESULTS
The initial search returned more than 10 000 hits; on the basis of the title or abstracts this was reduced to 91 studies and, after reading the papers, 55 studies (40 observational and 15 RCTs) were included in this review (see Fig. 1 ). The characteristics of these studies, including a summary of the results of the predictors' analysis, are presented in Supporting information, Table S1 .
Characteristics of the included studies
Design
Of the 40 observational studies, 19 were cross-sectional [21, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] and 21 were cohort studies [26, [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] . Fifteen studies used secondary data from RCTs [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] .
Study location
Of the observational studies, 12 were from North America (United States = 11, Canada = 1), 19 were European (multinational = 2, United Kingdom = 2, France = 1, Denmark = 1, Italy = 1, the Netherlands = 2, Norway = 4, Serbia = 1 and Spain = 5), five were from Asia (Japan = 2, Lebanon = 1, Taiwan = 1 and Israel = 1) and four were from Australasia (Australian = 3, New Zealand = 1). Twelve of the 15 RCTs were from the United States, two from the United Kingdom and one from France.
Participants
Among the 55 included studies, the combined total number of women who smoked before pregnancy was 505 584. All the studies recruited participants who were at least 16 years of age and the mean age of the women ranged from 16 to 50 years. Of the 17 studies (31.5%) that reported quit attempts, all or most of the participants made a quit attempt in 15 studies [21, 42, 46, 53, 68, 69, [72] [73] [74] [75] [76] 78, [80] [81] [82] , while two other studies reported quit attempts for only 17% [71] and 30% [45] of the participants.
Outcome of biochemical validation
Sixteen studies, three observational [31, 48, 63] 
Quality assessment
The median NOQAS [28, 29] score was 7.0 (range = 5-9) for cohort studies (including RCTs) and 6.6 (range = 4-8) for cross-sectional studies (see Supporting information, Tables S2, S3 . Nineteen (34.5%) were deemed to be of low quality. The main reasons for lower quality were non-representativeness of the underlying population, non-validation of self-reported outcome, low sample size or limited adjustment for potential confounders in the statistical analysis.
Smoking cessation rates
Smoking cessation rates reported in the 40 observational studies ranged from 4.0 to 76.2% and from 4.3 to 66.0% in the RCTs. 10 include non-smoking women or women who had stopped before pregnancy 3 reported predictors of postpartum cessation 4 did not report specific predictors 8 were qualitative research 5 reported intervention only 1 studied predictors of alcohol and tobacco use combined non-pregnant smokers 3 were previous reviews 10,662 papers were excluded as being not relevant or duplicates Figure 1 Flow diagram of eligible studies
Analysis techniques
For the majority of the included studies, statistical analyses to assess the associations were performed using simple and multiple logistic regression or mixed-effect logistic models, with smoking status during pregnancy as the dependent variable and other factors as independent variables. However, it is worth mentioning that the outcome definition is extremely heterogeneous (see column 4 in Supporting information, Table S1 ). Moreover, four of the RCTs [68, 69, 72, 73] and five of the observational studies [32, 34, 36, 40, 42] did not report adjusting for important potential confounders such as age, parity and cigarette dependence, or used analyses other than logistic or mixedeffect logistic regression. In addition, seven of the RCTs did not report adjusting for the effect of intervention [69, [71] [72] [73] 77, 79, 82] .
Predictors of smoking cessation
Fifty-four factors associated significantly with smoking cessation are presented in Table 1 and the forest plots are presented in Supporting information, Fig. S1 . When we repeated the synthesis for studies where most or all participants made a quit attempt similar factors were identified, and in particular there were significantly reported factors of socio-demographics, relationship and social activity, smoking behaviour, pregnancy, health status and psychological factors. No meaningful differences of predictors were identified in studies that used biochemical validation compared with those that did not. In the following sections, the statistically significant factors are classified into subgroups with a narrative description of the findings.
Socio-demographic factors
The socio-demographic factors that were associated significantly with higher likelihood of smoking cessation during pregnancy include older maternal age [21, 55, 58, 60, 61, 65, 76] , ethnicity: non-white [54] , non-Puerto Rican Hispanic [26, 37] and non-aboriginal [60, 65] , overseas maternal birth [37, 44, 60, 65] , higher level of maternal education [21, 26, 30, 33, 39, 43, 45, 47, 51, 53, 55, 57, 58, 61, 63, 66, 70, 71, 73, 79, 80, 82] or paternal education [53] , higher income level [21, 47, 52, 60] , currently employed women [62] and private Medicaid insurance [30, 51, 65, 77, 79] . In contrast, other studies found older age [26, 30, 40, 47, 51, 54, 66, 77] to be associated with a lower likelihood of smoking cessation during pregnancy.
Relationship and social activity factors
Women were more likely to quit during pregnancy if they were married or living with a partner [26,30,43,55,58,59,63,82], were housewives [43] and had support from partner and/or others [50] . Women were less likely to quit if they had a partner or household member who smoked [21, 36, 38, 41, 42, 44, 47, 48, 50, [62] [63] [64] 66, 67, 77] or had exposure to second-hand/ environmental smoking [39, 48, 63, 71, 81] , had a poor maternal childhood, defined as brought up without father being around or father's employment status was unknown to her, or had poor current circumstances, which is defined as becoming a mother at a younger age and currently not cohabiting [57] .
Smoking-or substance use-related factors
Smoking-related variables that predicted lower odds of cessation in pregnancy significantly included: higher cigarette consumption before pregnancy as a categorical variable [26,30,33,34,37- [78] , higher ratings of urges to smoke [36, 78] or withdrawal symptoms [36] , if women reported shorter time to smoke their first cigarette on awaking [75] [76] [77] , younger age at the onset of smoking [67, 82] and consumption of more coffee during pregnancy [64] . Women were more likely to quit if they: had smoked for a shorter duration [52, 81] , did not smoke their first cigarette within 30 minutes of awaking [75] [76] [77] , maintaining complete abstinence during the initial 2 weeks of quit attempt in early pregnancy [74] , had a pre-pregnancy/prior quit attempt [73, 75] , interaction of age and duration of smoking [i.e. younger (18-24 years) women who smoked for shorter duration (< 10 years)] [46] , used marijuana before pregnancy [37] , did not drink alcohol before and/or during pregnancy [47, 51, 53, 56] and interaction of delayed discounting and smoking rate at baseline (i.e. those who had delayed discounting of spontaneous quit and lower smoking rate at baseline) [82] .
Pregnancy-related factors
Pregnancy-related factors found to be associated significantly with a higher rate of smoking cessation during pregnancy were: primiparity (i.e. women with no previous pregnancy) [30, 31, 37, 39, [41] [42] [43] [44] [47] [48] [49] [51] [52] [53] 57, 59, 60, 62, 63, 65, 67, 72] , perceiving to have received adequate prenatal care [26, 41, 45, 52, 60, 65] , having planned breast feeding [26, 47, 54, 56] , having had a prior pre-term birth [26] and having had planned pregnancy [43, 44] .
Health-related factors
The health-related factors that were associated significantly with higher rates of smoking cessation were: severe nausea [48, 62] , family history of diabetes [37] , use of folic (Continues) acid [43] and had a known higher risk of fetal harm [36] . Women were less likely to quit who had short sleep duration [39] and were holders of a community services card (a health-care subsidy for low-income earners) [62] .
Psychological factors
Finally, the psychological predictors that were reported to be associated significantly with lower likelihood of smoking cessation were: higher levels of anxiety [35] or stress [35] [36] [37] 73, 82] and domestic violence [35] . Women were more likely to quit during pregnancy if they had no depression [31, 69, 70, 79] , had higher self-efficacy for quitting [32, 71, 76, 81] or readiness to quit [31] or held a stronger belief that smoking will harm their baby [82] .
Meta-analyses results
Meta-analyses were conducted for 18 of the factors, which have been reported by at least three studies and have effect estimates available. For all except age, the pooled effect estimates were significant statistically. The number of studies included in the meta-analysis, direction and sizes of effects (ORs, 95% CI) were as follows: older maternal age [categorical, 11 studies: 0. 96 Effect estimates extracted are odds ratios (OR: adjusted majority), relative risk ratios (RR: one study [26] ) or prevalence ratio (PR: one study [21] ). If an effect estimate was not reported, an unadjusted OR and 95% confidence interval (95% CI) was estimated from the available data. The effect estimate (e.g. OR) shows the direction of association; a factor is said to be associated with an increase likelihood of smoking cessation if OR > 1 and decrease likelihood if OR < 1. To ensure consistency of the effect estimates for meta-analysis, for some of the studies, the effect estimates are transformed to represent smoking cessation outcome and/or (appropriate category versus reference) of the predictor. c Using DerSimonian & Laird random-effects model for meta-analysis, the effect estimates were combined to compute a pooled OR for the association. Excluded two studies [34, 43] , as they reported OR (95% CI) for continuous score of the stress scale. *Studies methodology is classed as of high quality by the NOQAS (i.e. score of 7 and above). † Study(ies) with all or most of the participants made a quit attempt. * † Studies enclosed are fulfilling both of the above two criteria (* and †=(* and †).
#
The OR (95% CI) interpretation is incorrect in the original study, therefore it was not reported (NR): Effect estimate and/or 95% confidence intervals (CI) are not reported and cannot be estimated from the available results published in the study. I 2 : I-square is the measure (index) of heterogeneity among the studies included in the meta-analysis. More than 75% can be considered as high heterogeneity, more than 50% moderate and 25% as low heterogeneity [83] . P = represents the P-values for testing the hypothesis that the studies are homogeneous. Fig. S1 ).
Sources of heterogeneity
In the meta-analyses, the heterogeneity index I 2 ranged from 0 to 98.6%; it was very high (≥ 75%) for 10 of the factors (e.g. I 2 for categorical age is 96.0% and for continuous age is 88.9%, P < 0.001) and moderate (50% ≤ I 2 < 75%) for four factors [83] . For no alcohol use before and/or during pregnancy, planned breastfeeding, not having depression or having stress during pregnancy, there was no heterogeneity (I 2 = 0%); however, meta-analyses for the latter two factors exclude effect estimates from some of the studies (Table 1 and Supporting information, Fig. S1 ). Heterogeneity among the studies may be due to the design (i.e. RCT, observational cohort and cross-sectional), the use of different analytical techniques, outcome definition, differences in how the predictors (exposure) were measured or analysed in different studies, rates of smoking cessation, time of outcome assessment during pregnancy, study follow-up period and gestational age at baseline.
DISCUSSION
We extracted a wide range of factors that are associated with smoking cessation during pregnancy from 55 studies, including more than half a million women who smoked before pregnancy. The observed significant predictors of cessation were: higher socio-economic status (i.e. higher level of maternal education, higher income level or private Medicaid insurance), overseas maternal birth, living with partner or married, lower exposure to passive smoking (i.e. partner/other members of the household do not smoke or low exposure to second-hand smoking), low cigarette dependence (i.e. pre-pregnancy cigarettes consumption, lower time to first cigarette on waking, low baseline cotinine or heaviness of smoking index), low exposure to second-hand smoking, not drinking alcohol before and/or during pregnancy, primiparity, perceived adequate pre-natal care, planned breast feeding, good mental health during pregnancy (i.e. no depression or stress) and higher levels of self-efficacy for quitting. The findings have implications for the design of smoking cessation interventions and for public health policy. First, our findings, especially regarding sociodemographic and pregnancy related factors, can help to identify and prioritize women who are at increased risk of failing to quit or relapsing. This might include women who are of lower education, lower socio-economic status, multiparous and single. Secondly, some characteristics are likely to have a more direct impact on smoking cessation and might be most appropriate for including as intervention components. For example, high cigarette dependence, having a partner who smokes and low levels of self-efficacy for quitting can be targeted, respectively, by pharmaceutical interventions [84] , behavioural support that attempts to boost self-efficacy [85] and couple-focused interventions to help partners to quit [86] [87] [88] , where probably the most work is needed.
There are also characteristics that are likely to have a less direct impact on cessation, but that can still inform interventions. For example, more work is needed on depression-focused interventions [89] and interventions providing encouragement and incentives for breastfeeding [90, 91] .
There are some similarities and some difference between the factors associated with smoking cessation observed in this review and those reported for the general population of smokers. Factors which are also associated with cessation in the general population include higher socio-economic status, low cigarette dependence and higher levels of self-efficacy [92] ; whereas factors reported here, but not found for smokers in general, include marital status, no use of alcohol, good mental health and low exposure to second-hand smoke. Thus, while targeting and developing interventions for pregnant smokers there are several additional factors, including pregnancy-related factors, that needed to be considered.
Compared with a previous review of the predictors of smoking cessation during pregnancy [23] , we identified a broader set of predictors and included a larger number of studies based on up-to-date searches using robust review procedures. Also, we included studies from high-income countries globally and sought to include studies from low-middle income countries (LMICs), but identified only two studies from LMICs. Furthermore, a major limitation in previous reviews is the lack of included studies using biochemical confirmation of self-reported smoking cessation, and without such validation it is unclear what proportion of participants have falsified their smoking status. In our review, we included 15 studies that used data from RCTs, 13 of which used biochemical validation, and three of the observational studies also used biochemical validation. A further strength of our review compared with previous reviews is that we included a thorough study quality assessment using established scales [28, 29] .
A limitation with the literature reviewed is that the majority of studies are observational, used varied definitions for smoking cessation and had varying sample sizes. Some of the studies did not specifically seek to identify the predictors of smoking cessation, but reported them while evaluating the effect of an intervention. A further limitation with the findings is that the majority of the studies either did not report whether all participants made a quit attempt or reported that only some had made an attempt. These studies combined those who attempted to quit actively with those who did not. This may have distorted the findings, as a review of predictors of smoking behaviour in the general population of smokers identified that while many factors predict making a quit attempt, very few factors predict abstinence when including only those who actually made a quit attempt [92] . A further limitation was the quality of the studies included. On the basis of our quality assessment, 19 (35%) of the studies were considered to be of low quality due to low representativeness, low statistical power, design, analyses and no adequate follow-ups; however, we have highlighted the findings separately for the high-quality studies. It is worth acknowledging that NOQAS itself has known limitations; such as, it often does not inform the evidence synthesis process, particularly for systematic reviews of non-randomized studies, including sensitivity analysis, narrative assessment and restricting the synthesis to studies at a lower risk of bias, which have been discussed elsewhere in some detail [93] [94] [95] . However, NOQAS is a widely used tool for quality assessment in systematic reviews and we assessed the quality using NOQAS only and did not exclude any studies based on it. This is the first study, to our knowledge, to conduct meta-analysis for a range of predictors of cessation in pregnancy. Meta-analysis was conducted only for factors with effect estimates reported by at least three studies, and we could not include all estimates as the appropriate data were not always available. These analyses yielded important information concerning the strength of association and the amount of heterogeneity between studies. For example, when the effect estimates for maternal older age were pooled no significant effect was observed statistically, and there was high heterogeneity in effect estimates among the studies. There was a high degree of heterogeneity for many of the factors investigated, and we used a randomeffects model to allow for between-study heterogeneity. We have described potential sources of heterogeneity including study design, study population, measuring and assessing factors, outcome measure and timing of outcome measure during pregnancy and when there are sufficient studies, this could be explored in the future through meta-regression. The pooled analysis was weighted by the inverse of variance, but we did not use meta-regression to explore heterogeneity further. As such, the aim of this review was to report the findings narratively, and for the majority of the factors meta-analysis was not conducted due to being reported by fewer than three studies; hence, the meta-analyses results must be viewed and interpreted cautiously.
This review identified only two studies from LMICs (Serbia and the Lebanon); interestingly, the factors associated with smoking cessation in these countries were similar to those identified in women from the high-income nations (i.e. higher socio-economic status, other members of the household do not smoke, low cigarette dependence, perceived adequate pre-natal care). Further work is needed to explore whether the predictors are the same for LMICs versus high-income nations, particularly in relation to factors which are likely to be distinct in poorer nations, such as provision of health services and education. This issue is particularly important due to concerns that smoking among pregnant women in LMICs is declining more slowly compared with high-income countries.
Further research is also needed focusing upon predictors for which there were not consistent findings (e.g. maternal age) or where there were few high-quality studies showing significant effects (e.g. ethnicity, nicotine dependence, urges to smoke and psychological variables such as readiness to quit). It is not clear why the findings were inconsistent for maternal age, although this is likely to be due partly to variation in how the age variable was defined (e.g. categorical versus continuous) in the different studies. However, our thorough meta-analysis for age concluded that it is not a significant predictor. Research is also required to investigate predictors of quit attempts, which are likely to be distinct from the predictors of success of those attempts [92] . Finally, as has been performed with predictors of post-partum return to smoking [96] , studies are needed to explore direct and indirect pathways linking predictors with smoking cessation during pregnancy, thereby further focusing the priorities for intervention development.
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